CME launches event contracts amid regulator concerns

At G2E in Las Vegas, while state gaming regulators were telling anyone who would listen that prediction markets lose money for retail traders at an rate of nearly nine in ten, CME Group was in the same building announcing new event contracts. The timing was not accidental and the irony was not lost on anyone who trades these instruments for a living.

CME entering event contracts matters in a way that Kalshi's legal campaign, however consequential, does not fully capture. Kalshi is fighting for permission to exist. CME already exists — it is the largest derivatives exchange in the world by volume, it has a CFTC relationship built over decades, and it has clearing infrastructure that no prediction market startup has come close to replicating. When CME decides a product category is worth building, the question stops being whether the category survives and starts being what shape it takes when it does.

The 88 percent loss rate that gaming regulators cited at G2E is a real number and worth taking seriously. I have seen thin markets produce statistics that look damning and are technically accurate — the median participant loses because a small number of sophisticated participants extract most of the edge. That is not a scandal specific to prediction markets. It describes options markets, spread betting, and most retail-facing derivatives products that have ever been offered. The question is whether the product generates information of value to people who are not trading it, and whether the market structure can be improved. CME's entry suggests at least one institution with serious skin in the game thinks both answers are yes.

What CME brings that Kalshi cannot manufacture through litigation is institutional legitimacy at the clearing layer. A pension fund's compliance desk will engage with a CME-cleared contract in a way it will never engage with a Polymarket position. That changes who can express views in these markets, and it changes the information content of the prices that result. A market where the participants include institutions with genuine exposure to the underlying event is a better market than one populated primarily by retail speculators and a handful of professional arbitrageurs like me.

The G2E panel's criticism landed harder on the Kalshi model than on CME's entry, and I suspect that is where the regulatory debate now quietly bifurcates. State gaming commissions are fighting over jurisdiction on contracts that look like sports bets. CME's products will be positioned as financial instruments from the outset, cleared through established infrastructure, and aimed at a different customer. Those two tracks can coexist, and watching regulators treat them identically would be the real analytical error.